Multiple Myeloma in Relapse Completed Phase 2 Trials for Dexamethasone (DB01234)

IndicationStatusPhase
DBCOND0036092 (Multiple Myeloma in Relapse)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02176213Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple MyelomaTreatment
NCT01083602Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple MyelomaTreatment